The approval is expected to be extended following the anticipated final consent from the Israeli police department.

Despite overwhelming evidence debunking it, the vaccine-autism myth is rising, fueled by misinformation after the pandemic.

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...

This story was first published by investigative nonprofit. There was a time when Sharelle Menard thought her son would never ...

Exposure to the virus in utero may have affected children’s development, adding to a list of health problems emerging in the ...

Autism spectrum disorder children who are referred ... substantial quality in their research methodologies. Using the pain scale developed by Carr et al., as well as ABC questionnaires, we ...

Even as U.S. politics seemed to be locked into familiar patterns, a few faith leaders showed the ability to take the country ...

SciSparc (SPRC)announced the renewal of its approval from the Israeli Medical Cannabis Agency at the Israeli Ministry of Health to conduct its clinical trial for SCI-210 in children with autism ...

Does the "highly sensitive person" (HSP) label mask autism? Explore the scientific gaps in HSP, its overlap with autism, and ...

The Autism Spectrum Disorders License will prepare you to serve students ... And additional credits gained through an add-on license help educators move up on the salary scale. You can earn an add-on ...

From studies of the connections between neurons to interactions between the nervous and immune systems to the complex ways in which people understand ...